Innova Captab has debuted at Rs 456.10 on the BSE, up by 8.10 points or 1.80% from its issue price of Rs 448.
The scrip is currently trading at Rs 540.00, up by 92.00 points or 20.54% from its issue price. It has touched a high and low of Rs 541.00 and Rs 452.00 respectively. So far 11.05 lakh shares were traded on the counter.
The offering, which was open for subscription between December 21, 2023 and December 26, 2023 was subscribed 55.26 times. The issue price was fixed at Rs 448 per share i.e. at upper end of price band of Rs 426-448 apiece.
Innova Captab is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1689.80 |
| Dr. Reddys Lab | 1219.00 |
| Cipla | 1228.50 |
| Zydus Lifesciences | 937.25 |
| Lupin | 2313.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: